Candel Therapeutics Inc. logo

Candel Therapeutics Inc. (CADL)

Market Closed
8 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
5. 45
+0.12
+2.25%
After Hours
$
6. 40
+0.95 +17.43%
253.64M Market Cap
- P/E Ratio
0% Div Yield
874,168 Volume
-0.91 Eps
$ 5.33
Previous Close
Day Range
5.39 5.64
Year Range
4.25 14.6
Want to track CADL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
13 Nov 2025
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
6 Nov 2025
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
3 Sep 2025
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
12 Aug 2025
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
13 May 2025
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
14 Mar 2025
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
14 Nov 2024
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
4 Sep 2024
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
9 May 2024
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
27 Mar 2024
-
-
Candel Therapeutics Inc. logo
CADL Candel Therapeutics Inc.
10 Nov 2023
-
-

CADL Earnings Reports FAQ

What is the earnings per share (EPS) for CADL?

The current EPS is -0.91.

What is the company's earnings growth rate?

Candel Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Candel Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Candel Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for CADL at this time, as Candel Therapeutics Inc has no recent EPS data to calculate it.